CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $15,304,000 | +62.3% | 457,666 | 0.0% | 0.22% | +45.6% |
| Q1 2021 | $9,428,000 | +17.6% | 457,666 | 0.0% | 0.15% | +14.6% |
| Q4 2020 | $8,018,000 | +18.1% | 457,666 | 0.0% | 0.13% | +2.4% |
| Q3 2020 | $6,787,000 | +14.1% | 457,666 | 0.0% | 0.13% | -3.1% |
| Q2 2020 | $5,950,000 | +682.9% | 457,666 | 0.0% | 0.13% | +469.6% |
| Q1 2020 | $760,000 | -25.6% | 457,666 | 0.0% | 0.02% | -17.9% |
| Q4 2019 | $1,021,000 | +4.7% | 457,666 | 0.0% | 0.03% | -6.7% |
| Q3 2019 | $975,000 | -20.5% | 457,666 | 0.0% | 0.03% | -21.1% |
| Q2 2019 | $1,227,000 | – | 457,666 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |